This implies that reduced levels of hepatic BRD7 per se may not directly lead to the development of type 2 diabetes, but preventing the decrease of BRD7 caused by obesity is enough to stop the progression of type 2 diabetes. Here, BRD7 is linked to obesity due to melanocortin 4 receptor deficiency.